Diagnostic Medical Systems S.A. (EPA:ALDMS)

Market Cap	32.24M +45.2%
Revenue (ttm)	49.47M +9.2%
Net Income	-1.67M
EPS	-0.07
Shares Out	25.90M
PE Ratio	n/a
Forward PE	41.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,888
Open	1.240
Previous Close	1.245
Day's Range	1.225 - 1.245
52-Week Range	1.130 - 1.485
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About EPA:ALDMS

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafa...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 140
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALDMS

Financial Performance

In 2024, EPA:ALDMS's revenue was 48.86 million, an increase of 10.74% compared to the previous year's 44.12 million. Losses were -2.88 million, -41.77% less than in 2023.